Research Progress of Gal-3 and Chemerin in Coronary Heart Disease

冠心病(CHD)是全球范围内的主要心血管疾病死亡原因之一，其危害性不容忽视，近年来，研究显示半乳糖凝集素-3 (Gal-3)和趋化素(Chemerin)作为两种重要的心血管生物标志物在冠心病研究中受到了广泛关注。Gal-3在冠状动脉粥样硬化和斑块稳定性中发挥着重要作用，通过调节炎症反应、细胞增殖和凋亡等机制影响冠心病的发生和发展。Chemerin则主要通过调控脂肪代谢、炎症反应和血管内皮功能等途径参与冠心病的发展进程。本研究综述了Gal-3和Chemerin的基本特征及其在冠心病中的作用机制，同时探讨了它们在冠心病诊断、治疗及预后评估中的潜在应用价值，为冠心病的防治提供新的思路和方法。Coronary heart disease (CHD) is one of the leading causes of cardiovascular disease mortality worldwide, and its severity cannot be overstated. In recent years, studies have demonstrated that Galectin-3 (Gal-3) and Chemerin, as two important cardiovascular biomarkers, have garnered significant attention in CHD research. Gal-3 plays an important role in coronary atherosclerosis and plaque stability. It influences the occurrence and development of coronary heart disease by regulating inflammatory reaction, cell proliferation and apoptosis. Chemerin participates in the development of coronary heart disease by regulating lipid metabolism, inflammatory reaction and vascular endothelial function. In this study, we reviewed the basic characteristics of Gal-3 and Chemerin and their mechanisms of action in coronary heart disease, and discussed their potential application value in the diagnosis, treatment and prognosis evaluation of coronary heart disease, to provide new ideas and methods for the prevention and treatment of coronary heart disease.